Skip to main content

Innova Captab Ltd

Stage 2 · Advancing · week 19Setup 7.0 ★★ GoodStrong +6.5

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. More about the company

₹1,166.2
+2.14% today
₹6,674 Cr · Mid cap
Market Neutral — FadingHealth Care 45.7% in Stage 2-1.4 pts / 20dPharmaceuticals 53.8%+3.8 pts
Loading price chart…
vs 52W High
-10.1%
₹642.8 lo₹1,297.6 hi
10.1% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 19
1w13w26w
Week 19 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
35.1%
200 DMA: ₹863 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
1.07x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
MA20 trending up · +5.9% vs MA50 +8.6%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-0.8%
3M
+18.7%
6M
+67.3%
YTD
+62.3%
1Y
+41.2%
Sector
Health Care
↓ Peaking
Stage 2%
45.7%
20d Δ
-1.4pp
1M return
-1.8%
3M return
+4.4%
Sector Stage-2 % · last 20 days
This stock ranks #32 of 77 Stage 2 stocks in Health Care by RS.
Industry
Pharmaceuticals
↑ Building
Stage 2%
53.8%
20d Δ
+3.8pp
1M return
-0.9%
3M return
+3.6%
Industry Stage-2 % · last 20 days
Ranks #28 of 61 Stage 2 stocks in this industry.
Stage Cycle Timeline2023-12-29 → 2026-10-07
S? 43w
S2 16w
S4 28w
S2 18w
2023-12-292026-10-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 43w → S2 16w → S3 10w → S4 2w → S1 1w → S2 4w → S1 2w → S4 5w → S1 8w → S4 28w → S1 6w → S2 18w current
Total tracked: 144 weeks across 12 stage runs.
Scan Membership
Prop Scan
Latest: 2026-10-07
Pullback Hunter
Latest: 2026-08-10
60 appearances in last 60 days. First seen: 2026-07-24.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-07S2
Wk 19 · Vol 1.07x
2026-10-06S2
Wk 18 · Vol 0.65x
2026-10-05S2
Wk 18 · Vol 0.94x
2026-10-01S2
Wk 18 · Vol 2.58x
2026-09-30S2
Wk 18 · Vol 6.73x
2026-09-29S2
Wk 18 · Vol 1.64x
2026-09-28S2
Wk 17 · Vol 0.67x
2026-09-25S2
Wk 17 · Vol 0.38x
2026-09-24S2
Wk 17 · Vol 1.13x
2026-09-23S2
Wk 17 · Vol 5.62x
2026-09-22S2
Wk 17 · Vol 0.70x
2026-09-21S2
Wk 16 · Vol 1.33x
Sector Peers — Stage 2All →
KOPRAN
wk 19 · -5.0% from hi
9.0
SMSPHARMA
wk 3 · -3.0% from hi
8.7
KILITCH
wk 2 · -1.7% from hi
8.7
BAFNAPH
wk 17 · 0.0% from hi
8.6
ZIMLAB
wk 21 · 0.0% from hi
8.3
Moving averages & range
50 DMA
₹1,096.4
200 DMA
₹863
52W High
₹1,297.6
52W Low
₹642.8
5D Low
₹1,141.8
Resistance levels (recent highs)
20d High
₹1,297.6
60d High
₹1,297.6
120d High
₹1,297.6
250d High
₹1,297.6
Next resistance
+11.3%
to 20d High
P/E (TTM)
34.4
Forward 19.0
Earnings Growth (YoY)
+28.6%
Revenue +42.3%
ROE
+13.7%
Profit margin +8.6%
Dividend Yield
0.47%
P/B 4.7
About this companyHealth Care· Pharmaceuticals

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through a network of distributors and pharmacies, as well as online channels in various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.